Real-world clinical utility of Xpert MTB/RIF Ultra in the assessment of tuberculosis in a low-TB-incidence, high-resource setting

被引:0
作者
Kim, Jee Whang [1 ,2 ]
Patel, Hemu [3 ]
Halliwell, Richard [3 ]
Free, Robert C. [4 ]
Glimour-Caunt, Alison [2 ]
Pareek, Manish [1 ,5 ]
Woltmann, Gerrit [1 ,2 ]
Verma, Raman [1 ,2 ]
Perera, Nelun [3 ]
Haldar, Pranabashis [1 ,2 ]
机构
[1] Univ Leicester, Dept Resp Sci, Leicester, England
[2] Univ Hosp Leicester NHS Trust, Dept Resp Med, Leicester, England
[3] Univ Hosp Leicester NHS Trust, Dept Clin Microbiol, Leicester, England
[4] Univ Leicester, Sch Comp & Math Sci, Leicester, England
[5] Univ Leicester, Dev Ctr Populat Hlth, Leicester, England
关键词
Tuberculosis; Infection Control; Respiratory Infection; MYCOBACTERIUM-TUBERCULOSIS; DIAGNOSIS; TRANSMISSION; MICROSCOPY; ACCURACY; CULTURE;
D O I
10.1136/bmjresp-2024-002624
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Tuberculosis (TB) diagnosis in the UK is impacted by delay and suboptimal culture-based microbiological confirmation rates due to the high prevalence of paucibacillary disease. We examine the real-world clinical utility of Xpert MTB/RIF Ultra (Xpert-Ultra) as a diagnostic test and biomarker of transmissible infection in a UK TB service. Methods Clinical specimens from suspected TB cases triple tested (smear microscopy, mycobacterial culture and Xpert-Ultra) at University Hospitals of Leicester NHS Trust (1 March 2018-28 February 2019) were retrospectively analysed. Diagnostic sensitivity and specificity were calculated using positive MTB culture and clinical TB diagnosis as reference standards. The QuantiFERON (QFT) positive proportion of pulmonary TB (PTB) contacts was used as a metric of transmitted infection to evaluate Xpert-Ultra and smear grade as markers of infectiousness. Results 251 samples (188 respiratory) from 231 patients (86 TB) were analysed. Compared with microscopy, Xpert-Ultra had higher diagnostic sensitivity (24.7% vs 78.7%, p<0.001) and comparable specificity (97.5% vs 99.4%). Xpert-Ultra and culture had comparable sensitivity (78.7% vs 71.9%) and specificity (99.4% vs 100.0%). Incorporating Xpert-Ultra with culture increased microbiologically verified diagnosis to 91.7% for PTB and 75.9% for extrapulmonary TB, compared with 85.0% and 44.8%, using culture alone. In PTB, both smear and Xpert-Ultra grade were positively associated with the proportion of contacts testing QFT positive. However, Xpert-Ultra had a higher negative predictive value than smear (QFT-positive contacts 6.7% vs 17.7%). Conclusion In low-TB-burden settings, systematic adoption of Xpert-Ultra for clinical assessment of suspected TB can improve the proportion of microbiologically verified diagnoses and improve the stratification of transmission risk.
引用
收藏
页数:11
相关论文
共 29 条
  • [11] A REEVALUATION OF SPUTUM MICROSCOPY AND CULTURE IN THE DIAGNOSIS OF PULMONARY TUBERCULOSIS
    LEVY, H
    FELDMAN, C
    SACHO, H
    VANDERMEULEN, H
    KALLENBACH, J
    KOORNHOF, H
    [J]. CHEST, 1989, 95 (06) : 1193 - 1197
  • [12] Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF
    Lombardi, Giulia
    Di Gregori, Valentina
    Girometti, Nicolo
    Tadolini, Marina
    Bisognin, Francesco
    Dal Monte, Paola
    [J]. PLOS ONE, 2017, 12 (04):
  • [13] Xpert MTB/RIF Ultra CT value provides a rapid measure of sputum bacillary burden and predicts smear status in patients with pulmonary tuberculosis
    Martin-Higuera, M. C.
    Rivas, G.
    Rolo, M.
    Munoz-Gallego, I.
    Lopez-Roa, Paula
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [14] Confidence intervals for predictive values with an emphasis to case-control studies
    Mercaldo, Nathaniel D.
    Lau, Kit F.
    Zhou, Xiao H.
    [J]. STATISTICS IN MEDICINE, 2007, 26 (10) : 2170 - 2183
  • [15] Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study
    Mishra, Hridesh
    Reeve, Byron W. P.
    Palmer, Zaida
    Caldwell, Judy
    Dolby, Tania
    Naidoo, Charissa C.
    Jackson, Jennifer G.
    Schumacher, Samuel G.
    Denkinger, Claudia M.
    Diacon, Andreas H.
    van Helden, Paul D.
    Marx, Florian M.
    Warren, Robin M.
    Theron, Grant
    [J]. LANCET RESPIRATORY MEDICINE, 2020, 8 (04) : 368 - 382
  • [16] Using molecular testing and whole-genome sequencing for tuberculosis diagnosis in a low-burden setting: a cost-effectiveness analysis using transmission-dynamic modelling
    Mugwagwa, Tendai
    Abubakar, Ibrahim
    White, Peter J.
    [J]. THORAX, 2021, 76 (03) : 281 - 291
  • [17] Time-to-Detection in Culture Predicts Risk of Mycobacterium tuberculosis Transmission: A Cohort Study
    O'Shea, Matthew K.
    Koh, Gavin C. K. W.
    Munang, Melinda
    Smith, Grace
    Banerjee, Arpan
    Dedicoat, Martin
    [J]. CLINICAL INFECTIOUS DISEASES, 2014, 59 (02) : 177 - 185
  • [18] Three year evaluation of Xpert MTB/RIF in a low prevalence tuberculosis setting: A Scottish perspective
    Parcell, Benjamin J.
    Jarchow-MacDonald, Anna A.
    Seagar, Amie-Louise
    Laurenson, Ian F.
    Prescott, Gordon J.
    Lockhart, Michael
    [J]. JOURNAL OF INFECTION, 2017, 74 (05) : 466 - 472
  • [19] Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting
    Rice, Jason P.
    Seifert, Marva
    Moser, Kathleen S.
    Rodwell, Timothy C.
    [J]. PLOS ONE, 2017, 12 (10):
  • [20] Xpert MTB/RIF Testing in a Low Tuberculosis Incidence, High-Resource Setting: Limitations in Accuracy and Clinical Impact
    Sohn, Hojoon
    Aero, Abebech D.
    Menzies, Dick
    Behr, Marcel
    Schwartzman, Kevin
    Alvarez, Gonzalo G.
    Dan, Andrei
    McIntosh, Fiona
    Pai, Madhukar
    Denkinger, Claudia M.
    [J]. CLINICAL INFECTIOUS DISEASES, 2014, 58 (07) : 970 - 976